[Chronic obstructive pulmonary disease and coronary heart disease: approaches to the treatment of combined pathology].
This review concerns peculiarities of pharmacotherapy for patients with concomitant coronary heart disease and chronic obstructive pulmonary disease. It describes the main pharmacodynamic and pharmacokinetic properties of cholinolytics, beta-agonists, methylxanthines, corticosteroids, antibiotics, ACE inhibitors, calcium channel blockers, beta-blockers, nitrates, and anti-aggregants. These data are used to substantiate the application of these drugs to the treatment of overlapping pathologies with special reference to concomitant coronary heart disease and chronic obstructive pulmonary disease.
Bova
A A
AA
Lapitskiĭ
D V
DV
D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy*; D019141:Respiratory System Agents / Q000627:therapeutic use*
D002317:Cardiovascular Agents; D019141:Respiratory System Agents